Fairmount Healthcare Fund II L.P.

Fairmount Healthcare Fund II L.P. is Director & 10% Owner at Viridian Therapeutics, Inc.\DE (VRDN). They have made 2 open-market trades across 1 company since 2024, most recently 2026-02-09.

CIK 0001769651

Get an email the next time Fairmount Healthcare Fund II L.P. files.Follow for free

2 open-market purchases totalling $40.0M since 2024, never a sale. Too few scored purchases to measure a record yet.

Current Position

Ticker	Shares	Value
GLTO	5,809,000	$166.7M
VRDN	3,445,813	$65.6M
SYRE	406,038	$32.5M
MGEN	87,891	$2.0M
JBIO	1,897,677	—
Total		$266.8M

Shares reported on the most recent Form 4, priced at the 2026-02-12 close. 1 holding could not be priced and is excluded from the total.

Grade by Ticker

CVRDN

1 trade

Get an email the next time Fairmount Healthcare Fund II L.P. files

Free account. One email when the next filing comes in.

Follow Fairmount Healthcare Fund II L.P. for free

Buy Track Record

Filings2

Only 2 discretionary filings — too few to score

Discretionary filings only. 10b5-1 plan trades, tax withholding and option exercises are excluded, and each column is one row per filing rather than per execution lot.